Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Publication year range
1.
Sci Rep ; 11(1): 3849, 2021 02 15.
Article in English | MEDLINE | ID: mdl-33589697

ABSTRACT

Even though application of nanoparticles in medicine seems to provide unique solutions for drug delivery and diagnosis diseases, understanding interactions between nanoscale materials and biological systems is imperative. Therefore, this study determined the effect of different types of nanoparticles (NPs) on human endothelial cells and examined the types of toxicity responses they can induce. Four different types of NPs were tested (PLA/MMT/TRASTUZUMAB, PLA/EDTMP, PLGA/MDP, and Pluronic F127 MICELLES), representing three putative areas of application: anticancer therapy, scintigraphy, and cosmetology. The experiments were performed on immortalized human umbilical vein endothelial cells (HUVEC-STs). Light contrast phase microscopy as well as cell viability assays showed that only Pluronic F127 MICELLES decreased the number of HUVEC-STs in contrast to PLA/MMT/TRASTUZUMAB, PLA/EDTMP, and PLGA/MDP NPs, which altered cell morphology, but not their confluency. The tested NPs induced not only DNA strand-breaks and alkali-labile sites, but also internucleosomal DNA fragmentation, visualized as a DNA ladder pattern typical of apoptosis. Moreover, generation of free radicals and subsequent mitochondrial membrane potential collapse showed the significance of free radical production during interactions between NPs and endothelial cells. High concentrations of NPs had different degrees of toxicity in human endothelial cells and affected cell proliferation, redox homeostasis, and triggered mitochondrial dysfunction.


Subject(s)
Biomarkers , Homeostasis , Human Umbilical Vein Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells/metabolism , Nanoparticles , Apoptosis/drug effects , Cell Line , Cell Survival , Cells, Cultured , Chemical Phenomena , DNA Damage , DNA Fragmentation , Drug Carriers , Homeostasis/drug effects , Humans , Mitochondria/drug effects , Mitochondria/genetics , Mitochondria/metabolism , Nanoparticles/adverse effects , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Oxidative Stress , Particle Size
2.
Biochem Biophys Res Commun ; 521(3): 674-680, 2020 01 15.
Article in English | MEDLINE | ID: mdl-31685208

ABSTRACT

Galectin-3 (Gal-3) is a multifunctional glycan-binding protein that participates in many pathophysiological events and has been described as a biomarker and potential therapeutic target for severe disorders, such as cancer. Several probes for Gal-3 or its ligands have been developed, however both the pathophysiological mechanisms and potential biomedical applications of Gal-3 remain not fully assessed. Molecular imaging using bioluminescent probes provides great sensitivity for in vivo and in vitro analysis for both cellular and whole multicellular organism tracking and target detection. Here, we engineered a chimeric molecule consisting of Renilla luciferase fused with mouse Gal-3 (RLuc-mGal-3). RLuc-mGal-3 preparation was highly homogenous, soluble, active, and has molecular mass of 65,870.95 Da. This molecule was able to bind to MKN45 cell surface, property which was inhibited by the reduction of Gal-3 ligands on the cell surface by the overexpression of ST6GalNAc-I. In order to obtain an efficient and stable delivery system, RLuc-mGal-3 was adsorbed to poly-lactic acid nanoparticles, which increased binding to MKN45 cells in vitro. Furthermore, bioluminescence imaging showed that RLuc-mGal-3 was able to indicate the presence of implanted tumor in mice, event drastically inhibited by the presence of lactose. This novel bioluminescent chimeric molecule offers a safe and highly sensitive alternative to fluorescent and radiolabeled probes with potential application in biomedical research for a better understanding of the distribution and fate of Gal-3 and its ligands in vitro and in vivo.


Subject(s)
Galectin 3/metabolism , Luciferases, Renilla/metabolism , Luminescent Agents/metabolism , Neoplasms/diagnostic imaging , Polysaccharides/metabolism , Animals , Cell Line, Tumor , Galectin 3/analysis , Galectin 3/genetics , Humans , Luciferases, Renilla/analysis , Luciferases, Renilla/genetics , Luminescent Agents/analysis , Male , Mice , Mice, Inbred BALB C , Neoplasms/metabolism , Optical Imaging , Polysaccharides/analysis , Protein Binding , Protein Engineering , Recombinant Fusion Proteins/analysis , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
3.
Curr Drug Deliv ; 13(2): 221-35, 2016.
Article in English | MEDLINE | ID: mdl-26674198

ABSTRACT

Insects-borne diseases constitute a public health concern. Since there is no vaccine or curative treatment for many of these diseases, individual protection is the main approach to prevent them. Nowadays, the search for replacing synthetic molecules for insect repellents from natural sources, such as essential oils, is increasing. However, most of them present low efficiency compared to synthetic repellents. Therefore, decreasing skin permeation of synthetic repellents or yet, increasing effectiveness of natural repellents are challenges that must be overcome during the development of novel insect repellent formulations. In this context, polymer-based formulations allow entrapping active ingredients and provide release control. Encapsulation into polymeric micro/nanocapsules, cyclodextrins, polymeric micelles or hydrogels constitutes an approach to modify physicochemical properties of encapsulated molecules. Such techniques, applied in topical formulations, fabrics modification for personal protection, or food packaging have proved to be more effective in increasing repellency time and also in reducing drug dermal absorption, improving safety profiles of these products. In this work, the main synthetic and natural insect repellents are described as well as their polymeric carrier systems and their potential applications.


Subject(s)
Drug Delivery Systems/methods , Insect Bites and Stings/prevention & control , Insect Repellents/administration & dosage , Plant Oils/administration & dosage , Polymers/chemistry , Administration, Cutaneous , Animals , Chemistry, Pharmaceutical , Drug Compounding , Humans , Insect Repellents/adverse effects , Insecta/drug effects , Plant Oils/adverse effects , Skin Absorption
4.
Int J Nanomedicine ; 5: 961-71, 2010 Nov 15.
Article in English | MEDLINE | ID: mdl-21187948

ABSTRACT

Inhibition of tumor growth induced by treatment with direct electric current (DC) has been reported in several models. One of the mechanisms responsible for the antitumoral activity of DC is the generation of oxidative species, known as chloramines. With the aim of increasing chloramine production in the electrolytic medium and optimizing the antitumoral effects of DC, poly(ɛ-caprolactone) (PCL) nanoparticles (NPs) loaded with the amino acid tyrosine were obtained. The physical-chemical characterization showed that the NPs presented size in nanometric range and monomodal distribution. A slightly negative electrokinetic potential was also found in both blank NPs and L-tyrosine-loaded PCL NPs. The yield of the loading process was approximately 50%. Within 3 h of dissolution assay, a burst release of about 80% L-tyrosine was obtained. The in vitro cytotoxicity of DC was significantly increased when associated with L-tyrosine-loaded NPs, using a murine multidrug-resistant melanoma cell line model. This study showed that the use of the combination of nanotechnology and DC has a promising antineoplastic potential and opens a new perspective in cancer therapy.


Subject(s)
Antineoplastic Agents/administration & dosage , Electric Stimulation Therapy/methods , Melanoma, Experimental/therapy , Nanoparticles/administration & dosage , Tyrosine/administration & dosage , Animals , Antineoplastic Agents/chemistry , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Combined Modality Therapy , Electrochemical Techniques , Melanoma, Experimental/drug therapy , Melanoma, Experimental/pathology , Mice , Microscopy, Electron, Transmission , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Particle Size , Polyesters/chemistry , Trypan Blue , Tyrosine/chemistry
5.
Pharm Res ; 23(2): 360-6, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16341572

ABSTRACT

PURPOSE: In photodynamic therapy (PDT), topically applied aminolevulinic acid (5-ALA) is converted to protoporphyrin IX (PpIX), which upon light excitation induces tumor destruction. To optimize 5-ALA-PDT via improving the highly hydrophilic 5-ALA limited penetration into the skin, we propose the use of the known skin penetration enhancer, oleic acid (OA). METHODS: In vitro skin penetration and retention of 5-ALA (1% w/w) were measured in the presence or absence of OA (2.5, 5.0, and 10.0% w/w) in propylene glycol (PG) using porcine ear skin as the membrane. In vivo accumulation of PpIX, 4 h after application, was determined fluorometrically in healthy mice skin by chemical extraction of skin samples. In vivo PpIX fluorescence kinetics was also investigated by noninvasive techniques using an optical fiber probe, for 30 min up to 24 h after topical application of 1.0% 5-ALA + 10.0% OA in PG on hairless mice skins. RESULTS: The flux and in vitro retention of 5-ALA in viable epidermis increased in the presence of 10.0% (w/w) OA. The amounts of PpIX, evaluated both by chemical tissue extractions and in vivo measurements by an optical fiber probe, increased after applying 5-ALA formulations containing 5.0 or 10.0% OA. Moreover, in vivo kinetic studies showed an increase in skin PpIX accumulation when formulations containing 10% OA were used; PpIX accumulation was also maintained longer compared to controls. CONCLUSIONS: Both in vitro and in vivo results show the OA potential as an optimizer of 5-ALA skin delivery.


Subject(s)
Aminolevulinic Acid/administration & dosage , Aminolevulinic Acid/therapeutic use , Oleic Acid/pharmacology , Pharmaceutic Aids/pharmacology , Photochemotherapy , Photosensitizing Agents/administration & dosage , Photosensitizing Agents/therapeutic use , Skin Absorption/drug effects , Animals , Chemistry, Pharmaceutical , Fluorescent Dyes , Fluorometry , In Vitro Techniques , Mice , Mice, Hairless , Ovalbumin/metabolism , Serine Proteinase Inhibitors/metabolism , Swine
6.
Rev. chil. neurocir ; 25: 18-22, nov. 2005. tab, graf
Article in Spanish | LILACS | ID: lil-464189

ABSTRACT

Se presenta el análisis de 50 casos de tumores hipofisiarios operados en el Servicio de Neurocirugía de Valdivia, tanto por vía subfrontal, como por vía transesfenoidal, sus características clínicas, radiológicas, complicaciones, evolución y resultados. Se hace hincapié en las dificultades y facilidades que ofrecen ambas vías, acentuadas con los problemas que presenta la Neurocirugía en provincias.


Subject(s)
Male , Female , Adult , Middle Aged , Humans , Adenoma , Neoplasms, Glandular and Epithelial , Brain Neoplasms/classification , Brain Neoplasms/complications , Brain Neoplasms , Brain Neoplasms/therapy , Chile , Clinical Evolution , Brain Neoplasms/surgery , Brain Neoplasms/diagnosis , Postoperative Complications , Retrospective Studies
7.
Rev. chil. neurocir ; 18: 63-67, 2002. ilus
Article in Spanish | LILACS | ID: lil-388240

ABSTRACT

Se presenta el caso clínico de una menor de menos de tres años portadora de un meningioma gigante que invadía la región temporal, fose pterigomaxilar y órbita a izquierda. Se describe el manejo clínico quirúrgico y la evolución muy favorable del caso. Se revisa la literatura y se discute la poca frecuencia de este tipo de tumores en la edad pediátrica.


Subject(s)
Humans , Female , Child, Preschool , Case Management/trends , Meningioma/surgery , Meningioma/therapy
SELECTION OF CITATIONS
SEARCH DETAIL